Clearpoint Neuro Inc
CLPT10.295USD
+0.295+2.95%
交易中 （美东）报价延迟15分钟
288.06M总市值
亏损市盈率 TTM
关于 Clearpoint Neuro Inc 公司
ClearPoint Neuro, Inc. 是一家全球设备、细胞和基因治疗公司，为大脑和脊柱提供精确导航。该公司提供临床产品以及受控药物和设备输送的临床前开发服务。该公司的旗舰产品是 ClearPoint Neuro 导航系统。其首款产品 ClearPoint 系统是一个由资本设备和一次性产品组成的集成系统，旨在允许在磁共振成像 (MRI) 套件中对大脑进行微创手术。ClearPoint Array Neuro 导航系统及其主要一次性组件旨在部署在手术室环境中，同时也可用于 MRI 套件。它与北美、欧洲、亚洲和南美的医疗保健和研究中心合作。它还为全球临床前研究和临床试验中直接向中枢神经系统输送治疗剂提供解决方案。
公司简介
公司代码CLPT
公司名称Clearpoint Neuro Inc
上市日期Jul 03, 2019
CEOMr. Joseph Michael Burnett
员工数量115
证券类型Ordinary Share
年结日Jul 03
公司地址120 S. Sierra Avenue
城市SOLANA BEACH
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92075
电话19499006833
网址https://www.clearpointneuro.com/
公司代码CLPT
上市日期Jul 03, 2019
CEOMr. Joseph Michael Burnett
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.31K
+1.21%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
51.56K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mr. Jeremy L. Stigall
Mr. Jeremy L. Stigall
Chief Business Officer
Chief Business Officer
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.31K
+1.21%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
51.56K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Products: Functional neurosurgery
3.28M
38.62%
Services: Biologics and drug delivery
2.91M
34.31%
Products: Biologics and drug delivery
1.78M
20.98%
Services: Capital equipment and other
283.00K
3.34%
Product Systems and software products
234.00K
2.76%
地区USD
名称
营收
占比
United States
8.48M
100.00%
业务
地区
业务USD
名称
营收
占比
Products: Functional neurosurgery
3.28M
38.62%
Services: Biologics and drug delivery
2.91M
34.31%
Products: Biologics and drug delivery
1.78M
20.98%
Services: Capital equipment and other
283.00K
3.34%
Product Systems and software products
234.00K
2.76%
股东统计
更新时间: 5月15日 周四
更新时间: 5月15日 周四
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
5.22%
District 2 Capital LP
4.01%
PTC Therapeutics Inc
3.17%
Millennium Management LLC
2.62%
Susquehanna International Group, LLP
1.71%
Other
83.27%
持股股东
持股股东
占比
The Vanguard Group, Inc.
5.22%
District 2 Capital LP
4.01%
PTC Therapeutics Inc
3.17%
Millennium Management LLC
2.62%
Susquehanna International Group, LLP
1.71%
Other
83.27%
股东类型
持股股东
占比
Investment Advisor
15.28%
Hedge Fund
11.69%
Investment Advisor/Hedge Fund
5.88%
Individual Investor
5.24%
Corporation
3.17%
Research Firm
2.22%
Pension Fund
0.16%
Other
56.37%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
224
12.34M
43.65%
-23.48K
2025Q1
230
12.08M
42.76%
-158.33K
2024Q4
216
11.35M
41.09%
+117.64K
2024Q3
204
10.32M
38.18%
-558.62K
2024Q2
199
10.56M
39.44%
-945.58K
2024Q1
197
10.90M
40.86%
+64.32K
2023Q4
197
9.84M
39.93%
-1.22M
2023Q3
198
9.05M
36.76%
-2.10M
2023Q2
200
8.72M
35.43%
-782.48K
2023Q1
206
7.92M
32.20%
-48.15K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
1.28M
4.54%
+35.59K
+2.85%
Mar 31, 2025
District 2 Capital LP
1.13M
4.01%
+715.76K
+170.85%
Mar 31, 2025
PTC Therapeutics Inc
894.58K
3.17%
--
--
Aug 23, 2024
Millennium Management LLC
741.19K
2.62%
+452.04K
+156.34%
Mar 31, 2025
Susquehanna International Group, LLP
482.37K
1.71%
-26.79K
-5.26%
Mar 31, 2025
Bigger Capital Funds, LP
422.40K
1.49%
-688.79K
-61.99%
Mar 31, 2025
Bigger (Michael)
378.69K
1.34%
+20.00K
+5.58%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
368.02K
1.3%
-174.00
-0.05%
Mar 31, 2025
Brown Advisory
331.10K
1.17%
-2.30K
-0.69%
Mar 31, 2025
Essex Investment Management Company, LLC
327.46K
1.16%
-81.36K
-19.90%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
0.71%
Invesco NASDAQ Future Gen 200 ETF
0.46%
iShares Micro-Cap ETF
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
Motley Fool Next Index ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
占比0.71%
Invesco NASDAQ Future Gen 200 ETF
占比0.46%
iShares Micro-Cap ETF
占比0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.06%
Motley Fool Next Index ETF
占比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.02%
iShares Russell 2000 Growth ETF
占比0.02%
iShares Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
